Stockscreener 앱 받기
39.19
2.29%
-0.92
시간 외 거래:
39.22
0.03
+0.08%
전일 마감가:
$40.11
열려 있는:
$40.13
하루 거래량:
2.48M
Relative Volume:
0.67
시가총액:
$4.26B
수익:
-
순이익/손실:
$-95.90M
주가수익비율:
-29.69
EPS:
-1.32
순현금흐름:
$-79.09M
1주 성능:
-5.57%
1개월 성능:
+33.48%
6개월 성능:
+807.18%
1년 성능:
+581.57%
1일 변동 폭
$37.94
$40.48
1주일 범위
$37.94
$41.50
52주 변동 폭
$1.865
$48.26
턴스 파마슈티컬스 Stock (TERN) Company Profile
명칭
Terns Pharmaceuticals Inc
전화
650-525-5535 EXT.101
주소
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY
TERN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TERN
Terns Pharmaceuticals Inc
|
39.19 | 4.36B | 0 | -95.90M | -79.09M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
448.80 | 114.71B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
763.23 | 81.59B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.83 | 52.87B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
800.88 | 51.72B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.20 | 37.77B | 447.02M | -1.18B | -906.14M | -6.1812 |
턴스 파마슈티컬스 Stock (TERN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-04 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2025-11-03 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2025-10-15 | 개시 | Truist | Buy |
| 2025-09-17 | 개시 | Barclays | Overweight |
| 2025-09-04 | 재개 | H.C. Wainwright | Neutral |
| 2025-02-28 | 개시 | William Blair | Mkt Perform |
| 2024-10-31 | 개시 | Oppenheimer | Outperform |
| 2023-06-22 | 개시 | Mizuho | Buy |
| 2023-06-07 | 개시 | Jefferies | Buy |
| 2023-05-31 | 개시 | ROTH MKM | Buy |
| 2023-05-08 | 개시 | BMO Capital Markets | Outperform |
| 2023-02-14 | 개시 | JMP Securities | Mkt Outperform |
| 2023-02-07 | 개시 | UBS | Buy |
| 2022-09-12 | 개시 | H.C. Wainwright | Neutral |
| 2021-09-14 | 재개 | Goldman | Buy |
| 2021-03-02 | 개시 | Cowen | Outperform |
| 2021-03-02 | 개시 | Goldman | Buy |
| 2021-03-02 | 개시 | JP Morgan | Overweight |
모두보기
턴스 파마슈티컬스 주식(TERN)의 최신 뉴스
With 53% Institutional Ownership, Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Is a Favorite Amongst the Big Guns - 富途牛牛
Terns Pharmaceuticals reports inducement grants to new employees under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Terns Pharmaceuticals Reports Inducement Grants To New Employees Under Nasdaq Listing Rule 5635(C)(4) - TradingView — Track All Markets
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times
Tern Pharmaceuticals (TERN) Soars 630% on CML Treatment Best-in-Class Potential - Insider Monkey
Meet the 10 Market Stars Behind Millionaire-Making in 2025 - Insider Monkey
Terns Pharmaceuticals Earnings Notes - Trefis
The biggest end-of-year sale in the Bay Area was for $4 billion in biotech stock - The Business Journals
12 Overlooked Stocks That Delivered Massive Gains In 2025 - RTTNews
Terns Pharmaceuticals stock slides today, testing the $40 level after December share sale - ts2.tech
Terns Pharmaceuticals stock soars after leukemia drug delivers big early responses in tough-to-treat patients - MSN
Terns Pharmaceuticals (TERN) price target increased by 75.91% to 54.63 - MSN
Pharmaceutical Stocks To Follow TodayDecember 10th - MarketBeat
Terns Pharmaceuticals proposes $400M equity offering - MSN
Terns Pharmaceuticals (TERN) climbs 53% on stellar leukemia treatment trial - MSN
Truist Securities maintains Terns Pharmaceuticals (TERN) buy recommendation - MSN
Terns Pharmaceuticals (TERN) Is Down 7.7% After Strong TERN-701 Phase 1 DataHas The Bull Case Changed? - Sahm
Jim Cramer highlights massive gains for Terns Pharmaceuticals shareholders - MSN
Terns Pharmaceuticals (TERN) Price Target Increased by 75.91% to 54.63 - Nasdaq
Will Terns Pharmaceuticals Inc. stock gain from government policies2025 Bull vs Bear & Weekly High Potential Alerts - moha.gov.vn
How Terns Pharmaceuticals Inc. stock performs in weak economyEarnings Performance Report & High Conviction Trade Alerts - Улправда
Is Terns Pharmaceuticals Inc. stock attractive for long term wealth buildingJobs Report & Target Return Focused Stock Picks - Улправда
Jim Cramer Highlights Massive Gains for Terns Pharmaceuticals Shareholders - Finviz
Terns Pharmaceuticals unveils promising phase 1 trial data - MSN
Insider Trends: How Terns Pharmaceuticals Inc. stock performs in weak economyJuly 2025 Volume & Free Expert Approved Momentum Trade Ideas - Улправда
Is Terns Pharmaceuticals Inc. stock a contrarian buy2025 Price Momentum & Free High Accuracy Swing Entry Alerts - Улправда
Terns Pharmaceuticals (TERN) Stock Today (Dec. 18, 2025): Why Shares Are Sliding After the Rally, and What Analysts Forecast Next - ts2.tech
Jim Cramer Was Asked About These 11 Stocks - Insider Monkey
Operating cash flow per share of Terns Pharmaceuticals, Inc. – GETTEX:430 - TradingView — Track All Markets
Terns Pharmaceuticals (TERN) Stock Today: Latest News, Analyst Forecasts, and What to Watch (December 16, 2025) - ts2.tech
Terns Pharmaceuticals (TERN): Valuation Check After Strong CARDINAL Trial Data for CML Candidate TERN-701 - simplywall.st
Terns Pharmaceuticals, Inc. (TERN) Discusses Efficacy and Safety Data Update for TERN-701 in Chronic Myeloid LeukemiaSlideshow (NASDAQ:TERN) 2025-12-15 - Seeking Alpha
Terns CEO Amy Burroughs talks cancer drug trial win - CNBC
Biotech ETF SBIO Hovers Near Peak on Rally - ETF Database
Terns Pharmaceuticals raises $747.5 million in upsized offering - Traders Union
Terns Pharmaceuticals (TERN) Climbs 53% on Stellar Leukemia Treatment Trial - Finviz
10 Stocks Delivering Explosive 18-190% Gains - Insider Monkey
Terns Pharmaceuticals (TERN) Price Target Increased by 65.68% to 26.75 - MSN
Why Terns Pharmaceuticals (TERN) Is Up 73.6% After Upsized Equity Raise On Strong TERN-701 Data - Sahm
Terns Pharma (TERN) Stock Analysis Report | Financials & Insights - Benzinga
symbol__ Stock Quote Price and Forecast - CNN
Terns Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares - The Manila Times
Terns Pharmaceutical prices stock at $40 per share - MSN
Citizens Maintains Terns Pharmaceuticals (TERN) Market Outperform Recommendation - MSN
Terns Pharmaceuticals raises $747.5 million in public offering - Investing.com
Terns Pharmaceuticals raises $747.5 million in public offering By Investing.com - Investing.com Australia
턴스 파마슈티컬스 (TERN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.03%
0.06%
자본화:
|
볼륨(24시간):